We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mass Spectrometry Identifies Bacterial and Yeast Isolates

By LabMedica International staff writers
Posted on 24 Jan 2013
Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS) is an automated molecular platform that can be used to identify pathogens. More...


The MALDI-TOF technique effectively circumvents many of the drawbacks of other methods and offers a rapid, straightforward, and inexpensive method to distinguish bacteria and yeasts isolates from human samples.

Scientists at the Mayo Clinic’s Department of Laboratory Medicine and Pathology (Rochester, MN, USA) have recently validated the use of MALDI-TOF in the clinical laboratory. Currently, they only perform MALDI-TOF MS analysis from isolated bacterial and yeast colonies, therefore clinical specimens continue to be plated to solid media and are observed for growth. They use the process referred to as the formic acid-based, direct on-plate preparation method and depending on room humidity, has a total preparation time of 10 to 20 minutes for 24 samples.

The Bruker Biotyper MALDI-TOF MS (Fällanden, Switzerland) system is used for routine identification of bacterial and yeast isolates from culture. The Bruker Biotyper system includes the Microflex LT/SH MS instrument and two software programs: FlexControl for acquisition of protein spectra and Biotyper real-time classification (RTC) for automated spectral analysis.

The team has evaluated 900 bacterial and yeast isolates, with an overall correct identification rate of 94.2% to the genus and 79.2% to the species levels. While genus level identification was above 90% for most of the evaluated organism groups, the lower species level identification percentage was primarily driven by the gram-positive cocci (69.5%). Some closely related bacterial species cannot be differentiated by MALDI-TOF MS, regardless of the system manufacturer. This technology cannot reliably distinguish Escherichia coli from Shigella species or Streptococcus pneumoniae from S. mitis group species.

Identification of unknown isolates by this technology is based on the acquisition of unique protein profiles from isolated colonies and comparison of this data to a library of reference spectra derived from well-characterized isolates. The Mayo scientists have shown that has shown that MALDI-TOF MS is a rapid and inexpensive method able to accurately identify isolates within minutes, compared to the more time-consuming methods associated with other automated microbial identification systems and the potentially subjective nature of classic biochemical analyses.

Related Links:

Mayo Clinic
Bruker



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
Clinical Informatics Platform
CLARION™
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Molecular Diagnostics

view channel
Image: Researchers identified eight new DNA pattern signatures that could help refine diagnostics and guide targeted therapy in breast cancer (image credit: 123RF)

Breast Cancer-Specific Signatures Link Genome Instability to Outcomes

Genomic instability is a hallmark of cancer, but most genomic analyses have relied on broad signatures shared across multiple malignancies, limiting their precision for individual tumor types.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.